Submit Article
Back to Journal

SM Dermatology Journal

Melanoma Incidence Yesterday and Today - Where are we Going?

[ ISSN : 2575-7792 ]

Abstract
Details

Received: 25-Jun-2015

Accepted: 10-Jul-2015

Published: 14-Jul-2015

Editorial | Volume 1 - Issue 1 | Article DOI : https://dx.doi.org/10.36876/smdj.1001

Download PDF

Yusuke Suita and Elisabeth M Roider*

Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital,

Harvard Medical School, USA

Corresponding Author:

Elisabeth M Roider, Department of Dermatology,

Cutaneous Biology Research Center,

Massachusetts General Hospital,

Harvard Medical School, USA,

Abstract

Skin cancer is the most common cancer in the United States of America, including melanoma and non-melanoma skin cancer. Malignant melanoma, being ranked as the fifth most common cancer within the US shows a yearly incidence of 73,870 cases and remains the most aggressive form of all skin cancers with a mortality rate of 2.7 per 100,000 [1,2]. Fortunately, over the last decade melanoma treatment options have tremendously improved. Progress in areas such as immunotherapy and targeted therapies has lead to increased melanoma survival rates, rising from 82% (1975-1977) to 93% (2004-2010) [3]. In consequence, the cost of skin cancer treatments, specifically for melanoma treatments increased from an average annual total cost of $864 million in 2002 to $3349 million in 2011 [4].

Citation

Suita Y and Roider EM. Melanoma Incidence Yesterday and Today - Where are we Going? SM Dermatolog J. 2015; 1(1): 1001.